SCHEMBL4384650

SCHEMBL4384650

CC(=O)C(NCP(=O)(O)O)C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 1/20 0.35
GRIN3B O60391 1/20 0.35
GRIN1 Q05586 1/20 0.35
GRIN2A Q12879 1/20 0.35
GRIN2B Q13224 1/20 0.35
GRIN2C Q14957 1/20 0.35
GRIN3A Q8TCU5 1/20 0.35
MME P08473 3/20 0.33
ECE1 P42892 3/20 0.33
FOLH1 Q04609 3/20 0.32
PGK1 P00558 1/20 0.32
PGK2 P07205 1/20 0.32
CA2 P00918 1/20 0.32
CA4 P22748 1/20 0.32
GGH Q92820 1/20 0.32
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
LMNA P02545 1/20 0.31
HPGD P15428 1/20 0.31
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL523329 0.74 LTA4H (0.35) MMEECE1FOLH1PGK1PGK2
SCHEMBL523330 0.74 LTA4H (0.35) MMEECE1FOLH1PGK1PGK2
SCHEMBL2985678 0.72 CA2 (0.41) MMEECE1FOLH1CA2CA4
SCHEMBL7763267 0.71 CTH (0.38) MMEECE1LMNABLMTDP1
SCHEMBL896632 0.71 MME (0.36) MMEECE1FOLH1PGK1PGK2
SCHEMBL14502982 0.71 SMN1; SMN2 (0.36) MMEECE1CA2
SCHEMBL2991217 0.71 SMN1; SMN2 (0.36) MMEECE1CA2
SCHEMBL11799913 0.71 MME (0.33) MMEECE1FOLH1PGK1PGK2
SCHEMBL2991220 0.71 SMN1; SMN2 (0.36) MMEECE1CA2
SCHEMBL2983953 0.71 ECE1 (0.42) MMEECE1CA2CA4GGH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2124570-B1 METHODS FOR DETECTING GLYPHOSATE AND METABOLITES THEREOF DU PONT (US) 2016-11-16 EP claimed
EP-2124570-A1 METHODS AND COMPOSITIONS FOR DETECTING GLYPHOSATE AND METABOLITES THEREOF E. I. Du Pont de Nemours and Company (US) 2009-12-02 EP claimed
WO-2008118899-A1 METHODS AND COMPOSITIONS FOR DETECTING GLYPHOSATE AND METABOLITES THEREOF E.I. DU PONT DE NEMOURS AND COMPANY (US) 2008-10-02 WO claimed
CN-112280717-A Compound microbial agent, preparation method thereof and method for improving soil biological diversity 上海市农业科学院 2021-01-29 CN disclosed
EP-2124570-B1 METHODS FOR DETECTING GLYPHOSATE AND METABOLITES THEREOF DU PONT (US) 2016-11-16 EP disclosed
EP-2124570-A1 METHODS AND COMPOSITIONS FOR DETECTING GLYPHOSATE AND METABOLITES THEREOF E. I. Du Pont de Nemours and Company (US) 2009-12-02 EP disclosed
WO-2008118899-A1 METHODS AND COMPOSITIONS FOR DETECTING GLYPHOSATE AND METABOLITES THEREOF E.I. DU PONT DE NEMOURS AND COMPANY (US) 2008-10-02 WO disclosed
EP-1917360-A2 COMPOSITIONS PROVIDING TOLERANCE TO MULTIPLE HERBICIDES AND METHODS OF USE THEREOF Pioneer Hi-Bred International Inc. (US) 2008-05-07 EP disclosed
WO-2007024782-A2 COMPOSITIONS PROVIDING TOLERANCE TO MULTIPLE HERBICIDES AND METHODS OF USE THEREOF PIONEER HI-BRED INTERNATIONAL, INC. (US) 2007-03-01 WO disclosed
EP-1620557-A2 NOVEL GLYPHOSATE-N-ACETYLTRANSFERASE (GAT) GENES PIONEER HI-BRED INTERNATIONAL, INC. (US) 2006-02-01 EP disclosed
WO-2005012515-A2 NOVEL GLYPHOSATE-N-ACETYLTRANSFERASE (GAT) GENES PIONEER HI-BRED INTERNATIONAL, INC. (US) 2005-02-10 WO disclosed
EP-1399566-A2 NOVEL GLYPHOSATE N-ACETYLTRANSFERASE (GAT) GENES Maxygen, Inc. (US) 2004-03-24 EP disclosed
WO-2003092360-A2 NOVEL GLYPHOSATE-N-ACETYLTRANSFERASE (GAT) GENES VERDIA, INC. (US) 2003-11-13 WO disclosed
WO-2002036782-A2 NOVEL GLYPHOSATE N-ACETYLTRANSFERASE (GAT) GENES MAXYGEN, INC. (US) 2002-05-10 WO disclosed